Literature DB >> 3924602

Adherence inhibition assay: a specific serological test for detection of antibodies to Mycoplasma pneumoniae.

E Jacobs, K Schöpperle, W Bredt.   

Abstract

Antibodies directed against the adherence-mediating protein of Mycoplasma pneumoniae were measured by an adherence inhibition assay. Pretreatment with antibody-containing sera reduced the attachment of sheep erythrocytes to Mycoplasma pneumoniae layers grown in flat-bottom microtiter plates. The degree of attachment of erythrocytes was estimated by lysis with distilled water and measurement of absorbance in a microtiter reader. Sera tested included 126 sera from patients with suspected Mycoplasma pneumoniae respiratory infection and 60 sera from patients with serologically confirmed respiratory infection of other origin. Examination of human sera by both complement fixation using glycolipid as antigen, and the adherence inhibition assay indicated a high degree of specificity of the latter. Furthermore, titer increases parallel to complement fixation titers were found in six paired sera, and testing of separated IgM showed high reactivity in this immunoglobulin fraction. The adherence inhibition assay is a reproducible method which is relatively easy to perform. It may be of importance especially when a non-specific complement fixation reaction due to cross-reaction is suspected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924602     DOI: 10.1007/bf02013574

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  24 in total

1.  Immunological relationships between Mycoplasma pneumoniae and Streptococcus MG.

Authors:  K Lind
Journal:  Acta Pathol Microbiol Scand       Date:  1968

2.  Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis.

Authors:  M Kleemola; H Käyhty
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

3.  Mycoplasma pneumoniae adhesin localized to tip structure by monoclonal antibody.

Authors:  J Feldner; U Göbel; W Bredt
Journal:  Nature       Date:  1982-08-19       Impact factor: 49.962

4.  Adherence of erythrocytes to Mycoplasma pneumoniae.

Authors:  J Feldner; W Bredt; I Kahane
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  A J van Griethuysen; R de Graaf; J A van Druten; F W Heessen; J T van der Logt; A M van Loon
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

6.  Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques.

Authors:  H Brunner; B Prescott; H Greenberg; W D James; R L Horswood; R M Chanock
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

7.  Utilization of neuraminic acid receptors by mycoplasmas.

Authors:  R J Manchee; D Taylor-Robinson
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

8.  Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis.

Authors:  P O Leinikki; P Panzar; H Tykkä
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

9.  Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay.

Authors:  S M Räisänen; J I Suni; P Leinikki
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

10.  Host discrimination of Mycoplasma pneumoniae proteinaceous immunogens.

Authors:  D K Leith; L B Trevino; J G Tully; L B Senterfit; J B Baseman
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  8 in total

1.  A 168-kilodalton protein of Mycoplasma pneumoniae used as antigen in a dot enzyme-linked immunosorbent assay.

Authors:  E Jacobs; K Fuchte; W Bredt
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Number of specific antibody-secreting cells in the peripheral blood among children with mycoplasma pneumonia.

Authors:  M Iseki; T Takahashi; K Kimura; R Yamashita; T Sasaki
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Binding sites of attachment-inhibiting monoclonal antibodies and antibodies from patients on peptide fragments of the Mycoplasma pneumoniae adhesin.

Authors:  E Jacobs; B Gerstenecker; B Mader; C H Huang; P C Hu; R Halter; W Bredt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

Authors:  E Jacobs; A Bennewitz; W Bredt
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Characterization of the cellular response of spleen cells in BALB/c mice inoculated with Mycoplasma pneumoniae or the P1 protein.

Authors:  K Pietsch; E Jacobs
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

6.  Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.

Authors:  Nicol Schurwanz; Enno Jacobs; Roger Dumke
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

7.  Are outbreaks and sporadic respiratory infections by Mycoplasma pneumoniae due to two distinct subtypes?

Authors:  E Jacobs; M Vonski; K Oberle; O Opitz; K Pietsch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

8.  Biological activities of monoclonal antibodies to Mycoplasma pneumoniae membrane glycolipids.

Authors:  D K Chandler; L D Olson; J G Kenimer; P G Probst; S Rottem; M W Grabowski; M F Barile
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.